TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PharmaLogic Consulting AB
Closing information (x1000 EUR)
Closing information | 2022/09 | 2021/09 | 2020/09 |
Turnover | 19 | 268 | 518 |
Financial expenses | 21 | 0 | 0 |
Earnings before taxes | -112 | 172 | 396 |
EBITDA | -91 | 172 | 396 |
Total assets | 811 | 1,013 | 922 |
Current assets | 661 | 831 | 917 |
Current liabilities | 31 | 27 | 52 |
Equity capital | 737 | 921 | 810 |
- share capital | 5 | 5 | 5 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/09 | 2021/09 | 2020/09 |
Solvency | 90.9% | 90.9% | 87.9% |
Turnover per employee | 19 | 268 | 518 |
Profit as a percentage of turnover | -589.5% | 64.2% | 76.4% |
Return on assets (ROA) | -11.2% | 17.0% | 43.0% |
Current ratio | 2132.3% | 3077.8% | 1763.5% |
Return on equity (ROE) | -15.2% | 18.7% | 48.9% |
Change turnover | -232 | -267 | 429 |
Change turnover % | -92% | -50% | 486% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/09 | 2021/09 | 2020/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.